Literature DB >> 2647749

Genetically engineered polymers of human CuZn superoxide dismutase. Biochemistry and serum half-lives.

R A Hallewell1, I Laria, A Tabrizi, G Carlin, E D Getzoff, J A Tainer, L S Cousens, G T Mullenbach.   

Abstract

CuZn superoxide dismutase is a highly stable dimer of identical subunits with a combined molecular mass of 32,000 daltons. Two human superoxide dismutase genes have been joined in the same translational reading frame, using spacers of different lengths, to encode single chain proteins consisting of two identical human superoxide dismutase subunits. The first construct encodes two directly linked subunits; the terminal glutamine codon of the first gene was changed to a methionine codon and followed immediately by the second gene. The second construct encodes two subunits linked by a 19-amino-acid human immunoglobulin IgA1 hinge sequence. Both constructs produce high levels of catalytically active superoxide dismutase when expressed in Escherichia coli. The protein containing the IgA1 hinge sequence forms polymers up to 750,000 in molecular weight, which are linked together noncovalently by the hydrophobic bonding of the dimer interface. The polymers are soluble, thermostable, and of near normal specific activity. Site-directed in vitro mutagenesis was used to inactivate one of the two human superoxide dismutase subunits. The resulting human superoxide dismutase polymers have approximately 50% activity, thus confirming that the products of both genes are catalytically active. Large amounts of individual polymeric forms have been purified from recombinant yeast and tested for serum stability in rats. The serum half-life is approximately 7 min for both the two-chain wild type human superoxide dismutase dimer (Mr 32,000) and the single chain molecule consisting of a human superoxide dismutase dimer covalently linked by the immunoglobulin hinge region (Mr 34,000), whereas the higher molecular weight polymers (Mr greater than or equal to 68,000) all have half-lives of approximately 145 min.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2647749

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Atomic structures of wild-type and thermostable mutant recombinant human Cu,Zn superoxide dismutase.

Authors:  H E Parge; R A Hallewell; J A Tainer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

2.  Enhanced anti-inflammatory effects of Cu, Zn-superoxide dismutase delivered by genetically modified skin fibroblasts in vitro and in vivo.

Authors:  K Okumura; K Nishiguchi; Y Tanigawara; S Mori; S Iwakawa; F Komada
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

3.  Use of a novel hepatitis C virus (HCV) major-epitope chimeric polypeptide for diagnosis of HCV infection.

Authors:  D Y Chien; P Arcangel; A Medina-Selby; D Coit; M Baumeister; S Nguyen; C George-Nascimento; A Gyenes; G Kuo; P Valenzuela
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

Review 4.  Free radical ablation for the prevention of post-ischemic renal failure following renal transplantation.

Authors:  H J Schiller; K A Andreoni; G B Bulkley
Journal:  Klin Wochenschr       Date:  1991-12-15

5.  Contribution of human manganese superoxide dismutase tyrosine 34 to structure and catalysis.

Authors:  J Jefferson P Perry; Amy S Hearn; Diane E Cabelli; Harry S Nick; John A Tainer; David N Silverman
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162

Review 6.  The structural biochemistry of the superoxide dismutases.

Authors:  J J P Perry; D S Shin; E D Getzoff; J A Tainer
Journal:  Biochim Biophys Acta       Date:  2009-11-13

7.  Single chain dimers of MASH-1 bind DNA with enhanced affinity.

Authors:  M Sieber; R K Allemann
Journal:  Nucleic Acids Res       Date:  1998-03-15       Impact factor: 16.971

8.  The delivery of superoxide dismutase encapsulated in polyketal microparticles to rat myocardium and protection from myocardial ischemia-reperfusion injury.

Authors:  Gokulakrishnan Seshadri; Jay C Sy; Milton Brown; Sergey Dikalov; Stephen C Yang; Niren Murthy; Michael E Davis
Journal:  Biomaterials       Date:  2009-11-03       Impact factor: 12.479

9.  Two functional S100A4 monomers are necessary for regulating nonmuscle myosin-IIA and HCT116 cell invasion.

Authors:  Reniqua P House; Maria Pozzuto; Purvi Patel; Natalya G Dulyaninova; Zhong-Hua Li; Wendy D Zencheck; Michele I Vitolo; David J Weber; Anne R Bresnick
Journal:  Biochemistry       Date:  2011-07-13       Impact factor: 3.162

10.  Immunotargeting of antioxidant enzyme to the pulmonary endothelium.

Authors:  V R Muzykantov; E N Atochina; H Ischiropoulos; S M Danilov; A B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.